Article: Sen. Herb Kohl (D-WI) has asked commissioner Andrew von Eschenbach for info relating to the FDA's role in a decision by Genentech to limit availability of its cancer drug Avastin to certain drug compounding pharmacies.(Update)

Article: A U.S. senator said he is investigating Genentech Inc.'s (S. San ...
MondayMorning;  December 3, 2007 ;     597 words ... ... s (S. San Francisco) plan to stop supplying its cancer drug Avastin to pharmacies that divide vials of the medicine so it can ... Lucentis. In a statement released last week, Wisconsin Sen. Herb Kohl, chairman of the Senate's Special Committee on Aging ...

Article: Drug Avastin may help lung cancer patients live ...
Call and Post (Cincinnati);  May 18, 2005 ;     649 words ...Call and Post (Cincinnati) 05-18-2005 Certain lung cancer patients who take the drug Avastin (bevacizumab) along with standard chemotherapy live about two months longer than those who don't, the National Cancer Institute ...

Article: Genentech's drug, Avastin, helped cancer patients ...
Knight Ridder/Tribune Business News;  November 30, 2004 ;     700+ words ... ... Jacobs, San Jose Mercury News, Calif. Knight Ridder/Tribune Business News Nov. 30--Genentech's cancer drug Avastin helped boost survival for patients with colorectal cancer by two months, researchers announced Monday. While ...

Article: Warnings issued about cancer drug Avastin
The Milwaukee Journal Sentinel;  August 14, 2004 ;     256 words ...Warnings issued about cancer drug Avastin From Associated Press, Bloomberg News and New York Times reports Saturday, August 14, 2004 The government and Genentech are ...

Article: More good news for Genentech drug; Avastin helps ...
San Francisco Chronicle;  April 16, 2005 ;     700+ words ...Byline: Bernadette Tansey Genentech Inc.'s pioneering colon cancer drug Avastin, already showing potential as a lung cancer treatment, delivered significant benefits to breast cancer patients in clinical trial ...

Article: EU OKs Roche Colon Cancer Drug Avastin
AP Online;  January 14, 2005 ;     446 words ... ... Swiss pharmaceutical giant Roche Holding AG said Friday that the European Union's executive body had approved its cancer drug Avastin. Roche said the decision by the European Commission would allow it to distribute the colon cancer treatment across the 25 ...

Article: Roche stops recruiting patients for cancer drug ...
AP Worldstream;  February 13, 2006 ;     306 words ... ... BASEL, Switzerland Pharmaceutical maker Roche Holding AG said Monday it has stopped recruiting patients to test its cancer drug Avastin in late stage clinical trials after the deaths of four patients. The Basel-based company said it has stopped adding patients ...